5TIA image
Entry Detail
PDB ID:
5TIA
Keywords:
Title:
Crystal structure of human TDO in complex with Trp, Northeast Structural Genomics Consortium Target HR6161
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2016-10-01
Release Date:
2016-10-26
Method Details:
Experimental Method:
Resolution:
2.44 Å
R-Value Free:
0.22
R-Value Work:
0.16
R-Value Observed:
0.17
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tryptophan 2,3-dioxygenase
Chain IDs:A, B, C, D
Chain Length:380
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase.
Sci Rep 6 35169 35169 (2016)
PMID: 27762317 DOI: 10.1038/srep35169

Abstact

Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) play a central role in tryptophan metabolism and are involved in many cellular and disease processes. Here we report the crystal structure of human TDO (hTDO) in a ternary complex with the substrates L-Trp and O2 and in a binary complex with the product N-formylkynurenine (NFK), defining for the first time the binding modes of both substrates and the product of this enzyme. The structure indicates that the dioxygenation reaction is initiated by a direct attack of O2 on the C2 atom of the L-Trp indole ring. The structure also reveals an exo binding site for L-Trp, located ~42 Å from the active site and formed by residues conserved among tryptophan-auxotrophic TDOs. Biochemical and cellular studies indicate that Trp binding at this exo site does not affect enzyme catalysis but instead it retards the degradation of hTDO through the ubiquitin-dependent proteasomal pathway. This exo site may therefore provide a novel L-Trp-mediated regulation mechanism for cellular degradation of hTDO, which may have important implications in human diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures